ATE202112T1 - Neue sulfatierte lyso-gangliosidederivate - Google Patents

Neue sulfatierte lyso-gangliosidederivate

Info

Publication number
ATE202112T1
ATE202112T1 AT94911404T AT94911404T ATE202112T1 AT E202112 T1 ATE202112 T1 AT E202112T1 AT 94911404 T AT94911404 T AT 94911404T AT 94911404 T AT94911404 T AT 94911404T AT E202112 T1 ATE202112 T1 AT E202112T1
Authority
AT
Austria
Prior art keywords
gangliosides
lyso
sulfonyl
poly
dilyso
Prior art date
Application number
AT94911404T
Other languages
English (en)
Inventor
Aurelio Romeo
Gunter Kirschner
Carlo Chizzolini
Hari Manev
Laura Facci
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Application granted granted Critical
Publication of ATE202112T1 publication Critical patent/ATE202112T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94911404T 1993-03-04 1994-03-04 Neue sulfatierte lyso-gangliosidederivate ATE202112T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93PD000044A IT1267955B1 (it) 1993-03-04 1993-03-04 Derivati solfatati dei lisogangliosidi
PCT/US1994/001966 WO1994020516A1 (en) 1993-03-04 1994-03-04 New sulfated lyso-ganglioside derivatives

Publications (1)

Publication Number Publication Date
ATE202112T1 true ATE202112T1 (de) 2001-06-15

Family

ID=11390208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94911404T ATE202112T1 (de) 1993-03-04 1994-03-04 Neue sulfatierte lyso-gangliosidederivate

Country Status (9)

Country Link
EP (1) EP0688331B1 (de)
JP (1) JPH08507308A (de)
AT (1) ATE202112T1 (de)
AU (1) AU685787B2 (de)
CA (1) CA2157357A1 (de)
DE (1) DE69427468T2 (de)
ES (1) ES2157257T3 (de)
IT (1) IT1267955B1 (de)
WO (1) WO1994020516A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
JPH03246297A (ja) * 1990-02-22 1991-11-01 Nippon Koutai Kenkyusho:Kk ガングリオシド誘導体及びこれを含有する抗ｈｉｖ剤
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi
IT1267956B1 (it) * 1993-03-04 1997-02-18 Fidia S P A In Amministrazione Derivati o-solfatati di gangliosidi e lisogangliosidi

Also Published As

Publication number Publication date
CA2157357A1 (en) 1994-09-15
AU6393594A (en) 1994-09-26
IT1267955B1 (it) 1997-02-18
DE69427468D1 (de) 2001-07-19
AU685787B2 (en) 1998-01-29
DE69427468T2 (de) 2002-04-18
EP0688331A1 (de) 1995-12-27
ES2157257T3 (es) 2001-08-16
JPH08507308A (ja) 1996-08-06
WO1994020516A1 (en) 1994-09-15
ITPD930044A1 (it) 1994-09-04
EP0688331B1 (de) 2001-06-13
ITPD930044A0 (it) 1993-03-04

Similar Documents

Publication Publication Date Title
ATE211467T1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
ATE210127T1 (de) 6-substituierte mycophenolsäurederivate mit immun suppressiver wirkung
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
DE69226369D1 (de) System mit erhöhender Hautpenetration für verbesserte topische Verabreichung von Arzneimitteln
NO981436D0 (no) Farmasöytiske angiostatiske dipeptidsammensetninger og anvendelse derav
FI940375A0 (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
NZ230155A (en) N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions
ATE218616T1 (de) Humanes zirkulierendes cytokin cc-1
AU3539484A (en) Novel peptides which are active on the central nervous system and have an action on the cholinergic system
IT1270618B (it) Proteine ad attivita' antitumorale
ATE202112T1 (de) Neue sulfatierte lyso-gangliosidederivate
SE9400524L (sv) Energipreparat
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
MX9200755A (es) Tratamiento de carcinoma pulmonar de celulas no pequeñas.
ATE181669T1 (de) Verwendung von remacemid zur behandlung des morbus parkinson
ES2114170T3 (es) Peptidos con actividad organo-protectora, su procedimiento de preparacion y su utilizacion en la terapia.
RU95102777A (ru) Способ лечения реперфузного повреждения и "оглушения" миокарда
ITRM920773A0 (it) Procedimento per tonificare e migliorare la capacita' del sistema muscolare umano a produrre lavoro e mezzi per la realizzazione di detto procedimento.
ZA901992B (en) Antiviral compositions
DK0741746T3 (da) Thymosin alpha 1-analoger
ATE78160T1 (de) Verwendung von ''naftidrofuryl'' zur behandlung von neuropathien.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties